FindTrial
Sign In

A Retrospective Evaluation of Efficacy in the Management of Type 2 Diabetes Mellitus using Swayampurn Upchars Therapeutic

A Retrospective Evaluation of Swayampurn Upchars Therapeutic Efficacy in the Management of Type 2 Diabetes Mellitus. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/083900
Enrollment
200
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: NIL: NIL Intervention2: NIL: NIL Control Intervention1: Nil: Nil Control Intervention2: NIL: NIL

Sponsors

Niraamay Wellness Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: As a retrospective study, the inclusion criteria are Type 2 Diabetes (T2D) patients who have received Swayampurn Upchar therapy at Niraamay Wellness Center between 2015 and 2024, with available pre-treatment and post-treatment data.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1) To evaluate the effectiveness of Swayampurn Upchar in managing Type 2 Diabetes Mellitus among individuals affected by the condition. 2) To evaluate the impact of Swayampurn Upchar in reducing overall symptoms associated with Type 2 Diabetes among individuals affected by the condition.Timepoint: At baseline and post 6 months—

Secondary

MeasureTime frame
To evaluate improvements in laboratory parameters associated with the use of Swayampurn Upchar in the management of Type 2 Diabetes Mellitus.Timepoint: At baseline & post 6 months;To assess the impact of diabetes on mental health & emotional status by identifying common emotional responses & psychological challenges, including anxiety, depression, frustration, stress, & other related factors, among Study participants living with diabetes.Timepoint: At baseline & post 6 months—

Countries

India

Contacts

Public ContactNeelambari Bhosale

Niraamay Wellness Centre

chandorkar.yogesh@gmail.com7028020470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026